StudyManager Unveils Reveal Version 3.2
StudyManager
announced the release of Reveal 3.2, with enhanced features that provide greater ease of use and performance for research sites, academic medical centers, and hospitals.Reveal 3.2 provides a host of enhanced features focused on greater ease of use and performance including:
- Expanded fields and filters available in Reveal’s reporting tool, allowing clients to include and combine additional patient, scheduling, and financial information on custom views and then export them to Microsoft Excel
- A new, workflow-driven accrual activity “wizard,” making it easier for clients to track their revenue and receivables, create invoices, trigger holdbacks, and apply payments
- Increased performance of numerous key screens, including the Study “Visits & Procedures” screen, allowing clients to more quickly build their study schedule of events in a grid-style format that matches Sponsor documents
- A number of new workflow enhancements requested by clients, such as a new study search/select field that allows users to more quickly identify and select a study for patient enrollment
Reveal features focus on helping sites centralize study information, and:
- Improve clinical trial recruitment and enrollment results
- Negotiate more favorable contracts
- Ensure payment for all study activity–including items that have been historically difficult for sites to track such as screen-fails, holdbacks, and one-time fees
- Support clinical trial compliance efforts including federal patient privacy regulations, clinical compliance with sponsors’ protocols, and billing compliance to eliminate potential for double-billing of multiple payers
- Develop best practices and automate daily tasks to save time, reduce stress, and cut down on mistakes
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
